Muva nje, i-Guangdong Launca Medical Device Technology Co., Ltd. (Lapha ngemva kokubizwa ngokuthi yi-Launca medical) imemezele ukuthi isiqedele uxhaso olungeziwe lwe-Series-B lwamashumi ezigidi zamaRandi yi-TopoScend Capital. Ngaphambi kwalokhu, i-Launca Medical ithole amashumi ezigidi zamadola ngoxhaso lwe-Series-B ku-Guozhong Venture Capital ngoJanuwari walo nyaka.
Kusukela yasungulwa ngo-2013, i-Launca ibizibandakanya ekuhlinzekeni ngezixazululo ezintsha zodokotela bamazinyo bedijithali. Ngamalungelo ayo obunikazi, iLaunca yethule isithwebuli sayo sokuqala se-intraoral i-DL-100 ngo-2015, bese i-Launca iqhubeka nokwenza ngcono futhi iphindaphinda isithwebuli sayo sangaphakathi futhi yakhulula ngempumelelo i-DL-150, DL-202 kanye ne-DL-206 emakethe.
UDkt. Jian Lu, umongameli kanye nomsunguli we-Launca, uphethe i-PHD ye-California Institute of Technology. Ngesipiliyoni seminyaka engaphezu kwengu-13 ocwaningweni nasekukhangiseni kwezithombe ze-3D, uDkt. Jian Lu uyinhlanganisela yobuchwepheshe bobuchwepheshe nobuhlakani bebhizinisi. Ngaphansi kobuholi bakhe, u-Launca uhamba kancane ebheke emgomweni wokuletha idijithali kuwo wonke amazinyo.
Umkhiqizo wayo omusha we-DL-206 iskena se-intraoral sisetshenziswa kabanzi ekufakweni, ukubuyisela ubuhle, i-orthodontics engabonakali kanye neminye imikhakha. Kwenza ukusebenza kodokotela bamazinyo kusebenze kahle futhi kube lula. Kuyinketho ekhethwayo kubasebenzisi bodokotela bamazinyo kanye nochwepheshe emhlabeni wonke. Njengamanje, umkhiqizo usuthole ngempumelelo izitifiketi ze-CE ne-FDA.
Ngemuva kokuphothulwa koxhaso lwalo mzuliswano, i-Launca Medical izophinde isebenzise ukubambisana nabakhiqizi basenhla nomfula, isheshise ukusebenza kahle kocwaningo, ukuthuthukiswa kobuchwepheshe be-intraoral nezisombululo kulo mkhakha.
Ngasikhathi sinye, i-Launca izonaka kakhulu ingxenye ye-R&D nokusebenza eNyakatho Melika naseYurophu, iqhubeke nokwandisa izindawo zebhizinisi, ithuthukise ukwakheka ezweni nasemhlabeni, futhi ilethe inani elithe xaxa kubasebenzisi, izibhedlela zemitholampilo. kanye nabanikazi bamasheya.
I-TopoScend Capital ithi, Kunesikhathi esibucayi sokuguqulwa kwedijithali embonini yamazinyo. Njengebhizinisi emkhakheni wodokotela bamazinyo edijithali e-China, i-Launca medical yenze impumelelo enkulu kanye nempumelelo emakethe yesithwebuli sedijithali njengoba inikeza izixazululo zokutshala nokulungisa amazinyo. Bekanye ne-R & D eqinile kanye nethimba lokuqeqesha, bakha umgoqo wokuncintisana oyingqayizivele emkhakheni wedijithali we-3D we-intraoral. I-TopoScend Capital inethemba ngesakhiwo se-Launca yezokwelapha, futhi iyazethemba ekusizeni i-Launca ukuthi inwebe umngcele wayo ukuze ibe ibhizinisi elihamba phambili lezokwelapha eziphuzwayo zedijithali isikhathi eside.
Isikhathi sokuthumela: May-20-2021